Literature DB >> 22167594

Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.

Dana V Rizk1, Orlando Gutierrez, Emily B Levitan, William M McClellan, Monika Safford, Elsayed Z Soliman, David G Warnock, Paul Muntner.   

Abstract

BACKGROUND: Unrecognized myocardial infarctions (UMIs) are common in the general population but have not been well studied in patients with chronic kidney disease (CKD). The purpose of this study was to determine the prevalence and prognosis for mortality of UMI among adults with CKD.
METHODS: The current study included 18 864 participants in the population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) study who completed a baseline examination including a 12-lead electrocardiogram (ECG). UMI was defined as the presence of myocardial infarction (MI) by Minnesota ECG classification in the absence of self-reported or recognized MI (RMI). Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation and albuminuria using albumin-to-creatinine ratio from a spot urine sample. All-cause mortality was assessed over a median 4 years of follow-up.
RESULTS: The prevalence of UMI was 4, 6, 6 and 13% among participants with eGFR levels of ≥ 60, 45-59.9, 30-44.9 and <30 mL/min/1.73 m(2), respectively, and 4, 5, 7 and 10% among participants with albuminuria levels of <10, 10-29.9, 30-299.9 and ≥ 300 mg/g, respectively. Compared to those with no MI, the multivariable adjusted hazard ratio for all-cause mortality associated with UMI and RMI was 1.65 [95% confidence interval (CI): 1.09-2.49] and 1.65 (95% CI: 1.20-2.26), respectively, among individuals with an eGFR <60 mL/min/1.73 m(2) and 1.49 (95% CI: 1.03-2.16) and 1.88 (95% CI: 1.40-2.52) among individuals with albuminuria ≥ 30 mg/g. Conclusion UMIs are common among individuals with an eGFR <60 mL/min/1.73 m(2) and albuminuria and associated with an increased mortality risk.

Entities:  

Mesh:

Year:  2011        PMID: 22167594      PMCID: PMC3433770          DOI: 10.1093/ndt/gfr684

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  23 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure.

Authors:  Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer
Journal:  J Clin Epidemiol       Date:  2004-10       Impact factor: 6.437

3.  Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors.

Authors:  J H Medalie; U Goldbourt
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

4.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

5.  Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study.

Authors:  J R Margolis; W S Kannel; M Feinleib; T R Dawber; P M McNamara
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

6.  Landmark article (JAMA 1912). Clinical features of sudden obstruction of the coronary arteries. By James B. Herrick.

Authors:  J B Herrick
Journal:  JAMA       Date:  1983-10-07       Impact factor: 56.272

7.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

8.  Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study.

Authors:  L S Jónsdóttir; N Sigfusson; H Sigvaldason; G Thorgeirsson
Journal:  Eur Heart J       Date:  1998-07       Impact factor: 29.983

9.  Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study.

Authors:  E Sigurdsson; G Thorgeirsson; H Sigvaldason; N Sigfusson
Journal:  Ann Intern Med       Date:  1995-01-15       Impact factor: 25.391

10.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

Authors:  W B Kannel; R D Abbott
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

View more
  8 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

Review 2.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

3.  Race-sex differences in the management of hyperlipidemia: the REasons for Geographic and Racial Differences in Stroke study.

Authors:  Monika M Safford; Christopher M Gamboa; Raegan W Durant; Todd M Brown; Stephen P Glasser; James M Shikany; Richard M Zweifler; George Howard; Paul Muntner
Journal:  Am J Prev Med       Date:  2015-05       Impact factor: 5.043

4.  Silent myocardial infarction on preoperative electrocardiogram for kidney transplant patients: Impact on clinical outcomes may not be silent.

Authors:  Salvatore P Costa; Krista L Lentine
Journal:  Am J Transplant       Date:  2022-02-10       Impact factor: 9.369

5.  Midlife Cardiovascular Risk Factors and Late-Life Unrecognized and Recognized Myocardial Infarction Detect by Cardiac Magnetic Resonance: ICELAND-MI, the AGES-Reykjavik Study.

Authors:  Dorothea McAreavey; Jean-Sébastien Vidal; Thor Aspelund; Gudny Eiriksdottir; Erik B Schelbert; Olafur Kjartansson; Jie J Cao; Gudmundur Thorgeirsson; Sigurdur Sigurdsson; Melissa Garcia; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Andrew E Arai
Journal:  J Am Heart Assoc       Date:  2016-02-12       Impact factor: 5.501

6.  Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Yu Yang; Wensheng Li; Hailan Zhu; Xiong-Fei Pan; Yunzhao Hu; Clare Arnott; Weiyi Mai; Xiaoyan Cai; Yuli Huang
Journal:  BMJ       Date:  2020-05-07

7.  Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Emily B Levitan; Christopher Gamboa; Monika M Safford; Dana V Rizk; Todd M Brown; Elsayed Z Soliman; Paul Muntner
Journal:  Vasc Health Risk Manag       Date:  2013-02-05

Review 8.  Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.

Authors:  Wen-Juan Wang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Oncotarget       Date:  2017-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.